Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T21:53:30.247Z.
Calculation as of: 2026-10-06T21:53:30.247Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: efd168c3f67c3bcd8ce1d079285ce9769a1647edc12b2aee6a2fbd6fb78d637d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
First Tracks Biotherapeutics Inc
Market Cap
$1.10B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.09B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.10B
EV/EBIT Ratio
28.24x
TTM Avg
30.09x
3Y Avg
62.24x
5Y Avg
80.49x
Market Cap
$1.08B
EV/EBIT Ratio
37.20x
TTM Avg
43.03x
3Y Avg
33.26x
5Y Avg
35.95x
Market Cap
$1.11B
EV/EBIT Ratio
N/A
TTM Avg
384.12x
3Y Avg
797.29x
5Y Avg
797.29x
Market Cap
$1.13B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.13B
EV/EBIT Ratio
236.48x
TTM Avg
98.35x
3Y Avg
222.12x
5Y Avg
246.60x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| First Tracks Biotherapeutics Inc (TRAX) | $1.10B | N/A | N/A | N/A | N/A |
| OPKO Health, Inc. (OPK)vs › | $1.09B | N/A | 39.17x | 40.90x | 40.90x |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | N/A | N/A | N/A | N/A |
| STAAR Surgical Company (STAA)vs › | $1.10B | 28.24x | 30.09x | 62.24x | 80.49x |
| IRadimed Corporation (IRMD)vs › | $1.08B | 37.20x | 43.03x | 33.26x | 35.95x |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | N/A | 384.12x | 797.29x | 797.29x |
| Replimune Group, Inc. (REPL)vs › | $1.11B | N/A | N/A | N/A | N/A |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | N/A | N/A | N/A | N/A |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 236.48x | 98.35x | 222.12x | 246.60x |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.13B | 17.10x | 14.99x | 31.51x | 159.52x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
